Matches in SemOpenAlex for { <https://semopenalex.org/work/W2167747181> ?p ?o ?g. }
- W2167747181 endingPage "210" @default.
- W2167747181 startingPage "203" @default.
- W2167747181 abstract "In cystic fibrosis (CF) the defective CF transmembrane conductance regulator protein may be responsible for the impaired transport of glutathione (GSH), the first line defense of the lung against oxidative stress. The aim of this single-blind, randomized, placebo-controlled trial was to evaluate the effect of inhaled GSH in patients with CF.54 adult and 51 pediatric patients were randomized to receive inhaled GSH or placebo twice daily for 12 months.Twelve month treatment with inhaled GSH did not achieve our predetermined primary outcome measure of 15% improvement in FEV1%. Only in patients with moderate lung disease, 3, 6 and 9 months therapy with GSH resulted in a statistically significant increase of FEV1 values from the baseline. Moreover GSH therapy improved 6-minute walking test in pediatric population. GSH was well tolerated by all patients.Inhaled GSH has slight positive effects in CF patients with moderate lung disease warranting further study.ClinicalTrials.gov; No.: NCT01450267; URL: www.clinicaltrialsgov." @default.
- W2167747181 created "2016-06-24" @default.
- W2167747181 creator A5006141192 @default.
- W2167747181 creator A5013307007 @default.
- W2167747181 creator A5020903958 @default.
- W2167747181 creator A5027191782 @default.
- W2167747181 creator A5028562273 @default.
- W2167747181 creator A5029050826 @default.
- W2167747181 creator A5031755772 @default.
- W2167747181 creator A5032084875 @default.
- W2167747181 creator A5033692164 @default.
- W2167747181 creator A5036082730 @default.
- W2167747181 creator A5038537985 @default.
- W2167747181 creator A5046484083 @default.
- W2167747181 creator A5057925918 @default.
- W2167747181 creator A5059557407 @default.
- W2167747181 creator A5088509158 @default.
- W2167747181 creator A5090434699 @default.
- W2167747181 date "2015-03-01" @default.
- W2167747181 modified "2023-10-18" @default.
- W2167747181 title "Randomized, single blind, controlled trial of inhaled glutathione vs placebo in patients with cystic fibrosis" @default.
- W2167747181 cites W1822904756 @default.
- W2167747181 cites W1974970141 @default.
- W2167747181 cites W1980464376 @default.
- W2167747181 cites W1988226846 @default.
- W2167747181 cites W1989935661 @default.
- W2167747181 cites W1994220134 @default.
- W2167747181 cites W1996275666 @default.
- W2167747181 cites W2004274686 @default.
- W2167747181 cites W2020509022 @default.
- W2167747181 cites W2045458017 @default.
- W2167747181 cites W2053242101 @default.
- W2167747181 cites W2093997131 @default.
- W2167747181 cites W2096484542 @default.
- W2167747181 cites W2099647732 @default.
- W2167747181 cites W2113099754 @default.
- W2167747181 cites W2122581077 @default.
- W2167747181 cites W2127244193 @default.
- W2167747181 cites W2133254979 @default.
- W2167747181 cites W2135135858 @default.
- W2167747181 cites W2142535516 @default.
- W2167747181 cites W2143492871 @default.
- W2167747181 cites W2144947606 @default.
- W2167747181 cites W2146292644 @default.
- W2167747181 cites W2313949504 @default.
- W2167747181 cites W2333398204 @default.
- W2167747181 cites W4245666729 @default.
- W2167747181 doi "https://doi.org/10.1016/j.jcf.2014.09.014" @default.
- W2167747181 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25458463" @default.
- W2167747181 hasPublicationYear "2015" @default.
- W2167747181 type Work @default.
- W2167747181 sameAs 2167747181 @default.
- W2167747181 citedByCount "25" @default.
- W2167747181 countsByYear W21677471812015 @default.
- W2167747181 countsByYear W21677471812016 @default.
- W2167747181 countsByYear W21677471812017 @default.
- W2167747181 countsByYear W21677471812018 @default.
- W2167747181 countsByYear W21677471812019 @default.
- W2167747181 countsByYear W21677471812020 @default.
- W2167747181 countsByYear W21677471812022 @default.
- W2167747181 crossrefType "journal-article" @default.
- W2167747181 hasAuthorship W2167747181A5006141192 @default.
- W2167747181 hasAuthorship W2167747181A5013307007 @default.
- W2167747181 hasAuthorship W2167747181A5020903958 @default.
- W2167747181 hasAuthorship W2167747181A5027191782 @default.
- W2167747181 hasAuthorship W2167747181A5028562273 @default.
- W2167747181 hasAuthorship W2167747181A5029050826 @default.
- W2167747181 hasAuthorship W2167747181A5031755772 @default.
- W2167747181 hasAuthorship W2167747181A5032084875 @default.
- W2167747181 hasAuthorship W2167747181A5033692164 @default.
- W2167747181 hasAuthorship W2167747181A5036082730 @default.
- W2167747181 hasAuthorship W2167747181A5038537985 @default.
- W2167747181 hasAuthorship W2167747181A5046484083 @default.
- W2167747181 hasAuthorship W2167747181A5057925918 @default.
- W2167747181 hasAuthorship W2167747181A5059557407 @default.
- W2167747181 hasAuthorship W2167747181A5088509158 @default.
- W2167747181 hasAuthorship W2167747181A5090434699 @default.
- W2167747181 hasBestOaLocation W21677471811 @default.
- W2167747181 hasConcept C126322002 @default.
- W2167747181 hasConcept C142724271 @default.
- W2167747181 hasConcept C168563851 @default.
- W2167747181 hasConcept C181199279 @default.
- W2167747181 hasConcept C185592680 @default.
- W2167747181 hasConcept C204787440 @default.
- W2167747181 hasConcept C27081682 @default.
- W2167747181 hasConcept C2776151105 @default.
- W2167747181 hasConcept C2776938444 @default.
- W2167747181 hasConcept C2778428886 @default.
- W2167747181 hasConcept C2908647359 @default.
- W2167747181 hasConcept C538909803 @default.
- W2167747181 hasConcept C55493867 @default.
- W2167747181 hasConcept C71924100 @default.
- W2167747181 hasConcept C90924648 @default.
- W2167747181 hasConcept C99454951 @default.
- W2167747181 hasConceptScore W2167747181C126322002 @default.
- W2167747181 hasConceptScore W2167747181C142724271 @default.
- W2167747181 hasConceptScore W2167747181C168563851 @default.
- W2167747181 hasConceptScore W2167747181C181199279 @default.